Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
Authors
Keywords
-
Journal
GENE THERAPY
Volume 24, Issue 10, Pages 621-629
Publisher
Springer Nature
Online
2017-07-28
DOI
10.1038/gt.2017.69
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidermal Growth Factor Promotes Proliferation and Migration of Follicular Outer Root Sheath Cells via Wnt/β-Catenin Signaling
- (2016) Haihua Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
- (2016) XIAOLI ZHU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma
- (2016) Jing He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
- (2016) Malte B. Monin et al. JOURNAL OF SURGICAL RESEARCH
- CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
- (2016) Luisa Circelli et al. Oncotarget
- Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells
- (2015) Zhi-Yu Song et al. BIOMEDICINE & PHARMACOTHERAPY
- HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
- (2015) R Muralidharan et al. CANCER GENE THERAPY
- AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments
- (2015) YU-XIN LIAO et al. ONCOLOGY REPORTS
- Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer
- (2015) Jing Guo et al. TUMOR BIOLOGY
- Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma
- (2014) Xin-Yu Tan et al. Gut and Liver
- Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
- (2013) Emma Salomonnson et al. PLoS One
- Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
- (2013) Michael S. Anglesio et al. PLoS One
- Halting metastasis through CXCR4 inhibition
- (2012) Deborah M. Ramsey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Inhibition of stromal CXCR4 impairs development of lung metastases
- (2012) Crescenzo D’Alterio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
- (2012) Xuqi Li et al. CANCER LETTERS
- Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
- (2012) Ignacio Romero et al. ENDOCRINOLOGY
- Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling
- (2011) Ming Ma et al. CANCER LETTERS
- Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway
- (2011) Jia Wang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The role of SDF-1/CXCR4 axis in ovarian cancer metastasis
- (2010) Xiaoyan Shen et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Ovarian cancer mouse models: a summary of current models and their limitations
- (2009) Miranda Y Fong et al. Journal of Ovarian Research
- Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer
- (2008) Takuya Akashi et al. CANCER SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started